MeSH tree: D04.345.295
In a clinical guideline issued by the American College of Gastroenterology and published in the March issue of the American Journal of Gastroenterology, recommendations are presented for the diagnosis and management of hepatic ...
Mar 17, 2026
0
6
Researchers at the University of Oulu have identified a previously unknown mechanism in humans that may explain why certain medicines and environmental chemicals disrupt the balance of sex hormones. The finding deepens scientific ...
Mar 11, 2026
0
8
The presence of circulating tumor DNA (ctDNA) in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer after they received neoadjuvant treatment and surgery predicted worse outcomes than in ...
Jan 14, 2026
0
11
A higher dose of the antibiotic rifampicin does not improve survival rates for patients with tuberculous meningitis. This severe form of tuberculosis causes inflammation of the brain membranes, and half of the patients die. ...
Dec 17, 2025
0
13
In a landmark moment at the ESMO Congress 2025, pivotal studies have unveiled compelling evidence that a new class of anti-cancer agents—antibody-drug conjugates (ADCs)—can dramatically improve outcomes for patients with ...
Oct 20, 2025
0
14
Cornell researchers have identified an antibiotic, rifampin, that is 99.9% effective against Salmonella Typhi, the bacterium that causes typhoid fever. Researchers also predict that rifampin will work on other life-threatening ...
Jun 16, 2025
0
37
In a classic example of scientific problem solving, scientists from the Hackensack Meridian Center for Discovery and Innovation (CDI) and colleagues have published a paper introducing a promising new drug candidate they engineered ...
May 2, 2025
0
41
A case report published in Eurosurveillance on an adult with an imported case of leprosy in Ireland shows that there are notable challenges in tackling the disease in settings where it is rare.
Jan 23, 2025
0
14
In patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of death or invasive disease by 46% and improved survival compared ...
Jan 15, 2025
0
48
For patients with a history of overt hepatic encephalopathy (OHE), rifaximin monotherapy (MT) results in significantly fewer OHE episodes than lactulose (LAC) MT, according to a study presented at the annual meeting of the ...
Oct 28, 2024
0
16
